Publication

Ultra Selective and Sensitive Electrochemical Detection of Anti-Cancer and Anti-Viral Drugs by Optimized Nano-Bio-Sensors

Nima Aliakbarinodehi
2017
Thèse EPFL
Résumé

Reliable, low cost, and accessible drug monitoring systems for individualized healthcare, especially chemotherapy for malignant diseases like prostate cancer and AIDS, are highly desira-ble. This is even more critical for drugs like abiraterone and TFV, with very narrow and low (submi-cro-molar) therapeutic windows. Point-of-care biosensors for drug monitoring offer a solution for this kind of therapy: bringing treatments to the patient’s bedside and eliminating interfering factors in medical treatments like interindividual differences (genetic profile, age, race, gender, etc.), environmental agents and the influences of other drugs (drug-drug interactions, adverse effects, etc.). Moreover, point-of-care biosensors provide access to reliable, fast and cheap cutting-edge technology for a large popula-tion. In particular, such a novel chemical therapy will suppress the morbidity rate and treatment time, as well as providing better screening of patients, and tighter monitoring of treatment. Con-sequently, this would lead to an improvement in patients’ medical treatments and overall quality of life. In other words, improved treatment efficacy and less side effects for patients. The objective of this thesis is to investigate biosensors for the monitoring of drugs for chemother-apeutic treatment for prostate cancer and AIDS. The first part of this work is devoted to the devel-opment of biosensors to target three main groups of drugs : electroactive drugs, drugs that involve an enzyme in their metabolic pathway and drugs that are neither electroactive nor interact with enzymes in the body. The second part is devoted to offering a reliable solution for selective and sensitive point-of-care biosensing for anti-prostate cancer drugs and anti-AIDS drugs. Screen-printed based biosensors with nanofunctionalization are offered for electroactive drug detection as a solution for prostate-cancer personalized medicine. Several steps of optimization have been performed to boost their electrochemical performance towards detection of Etoposide (a prostate cancer drug) in its therapeutic range, and also preparing the biosensor for the devel-opment of an enzymatic biosensor. Furthermore, they have been used to observe the quantum blockage in gold nanoparticles, and to investigate its impact on the biosensing performance. Secondly, an enzymatic biosensor for monitoring drugs, which involve cytochrome P450 enzymes in their metabolic pathway in the body, is presented as a second solution for prostate-cancer per-sonalized medicine. This kind of sensor is produced by immobilizing the cytochrome P450 enzyme over the already-mentioned optimized biosensor. The biosensor is utilized for investigating abi-raterone electrochemistry, and subsequently the detection of abiraterone in buffer and human serum are reported for the first time. Finally, affinity-based biosensors are proposed to address the detection of drugs that are neither electroactive nor interact with enzymes in body. Tenofovir, an anti-HIV drug, is targeted in this case to help find also a solution for HIV personalized medicine. To this aim, an aptamer-based sensing surface is obtained and optimized after intensive optimiza-tion, and the experimental testing of different possible surfaces. This surface is formed on the ac-tive part of a field-effect transistor transducer, and also a memristive nanowire transducer as a recognition element to develop the affinity based biosensors.

À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.
Concepts associés (40)
Biosenseur
Un biosenseur (aussi appelé biocapteur) est un dispositif détecteur, semi-biologique associant trois éléments : l'échantillon à étudier : eau, air, sol, matériel biologique (tissus, micro-organismes, organites, récepteurs cellulaires, enzymes, anticorps, acides nucléiques, organismes génétiquement modifié, ou matériel issu d'OGM, etc.) un élément capteur (éventuellement sous la forme d'une puce électronique) détectant des changements physico-chimiques sous forme de signaux (présence/absence) biochimiques et/ou physiques ou chimique dans un milieu (externe ou interne au corps humain) et émettant un signal biologique.
Cancer de la prostate
vignette|Prostate et vésicules séminales (normales) Le cancer de la prostate est un cancer fréquent touchant la prostate, une glande de l'appareil reproducteur de l'homme. Le cancer se développe à partir des tissus de la prostate quand des cellules y mutent et se multiplient de façon incontrôlée. Celles-ci peuvent ensuite s'étendre (se métastaser) en migrant de la prostate jusqu'à d'autres parties du corps, particulièrement les os et les ganglions lymphatiques du pelvis.
Prostate
vignette|Représentation de la prostate de : déférent, du conduit déférent, séminale, excréteur de la vésicule séminale, de prostate, éjaculateur, prostatique, glandulaire, de l'urètre, séminal, urétrale La prostate est une glande exocrine de l'appareil génital masculin. Sa fonction principale est de sécréter une partie du liquide séminal (20 %), l'un des constituants du sperme, et de le stocker. Chez la femme, les glandes para-urétrales (aussi appelées glandes de Skene) sont parfois désignées comme une prostate féminine.
Afficher plus
Publications associées (48)

Il-10 expressing cells for enhanced cancer immunotherapies

Li Tang, Yugang Guo, Yang Zhao

The present invention relates generally to the field of anti-cancer therapy, in particular to the use of adoptive T cell transfer therapy for treating cancer, in particular sold tumors. More specifically, the present invention relates to immune cells compr ...
2023

Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers

Wouter Richard Karthaus

In lung and prostate adenocarcinomas, neuroendocrine (NE) transformation to an aggressive derivative resembling small cell lung cancer (SCLC) is associated with poor prognosis. We previously described dependency of SCLC on the nuclear transporter exportin ...
2023

Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets

Christoph Merten, Ngoc Hien Du

Anti-cancer therapies often exhibit only short-term effects. Tumors typically develop drug resistance causing relapses that might be tackled with drug combinations. Identification of the right combination is challenging and would benefit from high-content, ...
2022
Afficher plus

Graph Chatbot

Chattez avec Graph Search

Posez n’importe quelle question sur les cours, conférences, exercices, recherches, actualités, etc. de l’EPFL ou essayez les exemples de questions ci-dessous.

AVERTISSEMENT : Le chatbot Graph n'est pas programmé pour fournir des réponses explicites ou catégoriques à vos questions. Il transforme plutôt vos questions en demandes API qui sont distribuées aux différents services informatiques officiellement administrés par l'EPFL. Son but est uniquement de collecter et de recommander des références pertinentes à des contenus que vous pouvez explorer pour vous aider à répondre à vos questions.